Loss of Heterozygosity Analysis at Different Chromosome Regions in Wilms Tumor Confirms 1p Allelic Loss as a Marker of Worse Prognosis: A Study from the Italian Association of Pediatric Hematology and Oncology EDITORIAL COMMENT

被引:0
|
作者
Romao, Rodrigo [1 ,2 ]
Lorenzo, Armando J. [3 ]
机构
[1] Dalhousie Univ, Dept Surg, IWK Hlth Ctr, Halifax, NS B3H 4H2, Canada
[2] Dalhousie Univ, Dept Urol, IWK Hlth Ctr, Halifax, NS, Canada
[3] Univ Toronto, Hosp Sick Children, Div Urol, Toronto, ON M5G 1X8, Canada
来源
JOURNAL OF UROLOGY | 2013年 / 189卷 / 01期
关键词
D O I
10.1016/j.juro.2012.09.175
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:266 / 266
页数:1
相关论文
共 5 条
  • [1] Loss of Heterozygosity Analysis at Different Chromosome Regions in Wilms Tumor Confirms 1p Allelic Loss as a Marker of Worse Prognosis: A Study from the Italian Association of Pediatric Hematology and Oncology
    Spreafico, Filippo
    Gamba, Beatrice
    Mariani, Luigi
    Collini, Paola
    D'Angelo, Paolo
    Pession, Andrea
    Di Cataldo, Andrea
    Indolfi, Paolo
    Nantron, Marilina
    Terenziani, Monica
    Morosi, Carlo
    Radice, Paolo
    Perotti, Daniela
    JOURNAL OF UROLOGY, 2013, 189 (01): : 260 - 266
  • [2] Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: A report from the National Wilms Tumor Study Group
    Grundy, PE
    Breslow, NE
    Li, S
    Perlman, E
    Beckwith, JB
    Ritchey, ML
    Shamberger, RC
    Haase, GM
    D'Angio, GJ
    Donaldson, M
    Coppes, MJ
    Malogolowkin, M
    Shearer, P
    Thomas, PRM
    Macklis, R
    Tomlinson, G
    Huff, V
    Green, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (29) : 7312 - 7321
  • [3] Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report
    Dix, David B.
    Fernandez, Conrad V.
    Chi, Yueh-Yun
    Mullen, Elizabeth A.
    Geller, James I.
    Gratias, Eric J.
    Khanna, Geetika
    Kalapurakal, John A.
    Perlman, Elizabeth J.
    Seibel, Nita L.
    Ehrlich, Peter F.
    Malogolowkin, Marcio
    Anderson, James
    Gastier-Foster, Julie
    Shamberger, Robert C.
    Kim, Yeonil
    Grundy, Paul E.
    Dome, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (30) : 2769 - +
  • [4] Augmentation of therapy for favorable-histology Wilms Tumor with combined loss of heterozygosity of chromosomes 1p and 16q: A report from the Children's Oncology Group studies AREN0532 and AREN0533.
    Dix, David B.
    Fernandez, Conrad Vincent
    Chi, Yueh-Yun
    Anderson, James Robert
    Mullen, Elizabeth Anne
    Geller, James I.
    Gratias, Eric J.
    Khanna, Geetika
    Kalapurakal, John A.
    Perlman, Elizabeth Jones
    Seibel, Nita
    Ehrlich, Peter F.
    Malogolowkin, Marcio H.
    Gow, Kenneth William
    Hamilton, Thomas Edward
    Grundy, Paul Edward
    Dome, Jeffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532
    Evageliou, Nicholas
    Renfro, Lindsay A.
    Geller, James
    Perlman, Elizabeth
    Kalapurakal, John
    Paulino, Arnold
    Dix, David
    Eklund, Meryle J.
    Murphy, Andrew J.
    Romao, Rodrigo L. P.
    Ehrlich, Peter F.
    Varela, Carly R.
    Vallance, Kelly
    Fernandez, Conrad V.
    Dome, Jeffrey S.
    Mullen, Elizabeth A.
    CANCER, 2024, 130 (05) : 792 - 802